YORBA LINDA, Calif. (PRWEB) September 14, 2018
Next-generation genomic sequencing is transforming what is known about pediatric cancer and how we treat patients. But even with new technologies, challenges remain. In the past, the sheer size of genomics data has made sharing across the global scientific community a challenge.
St. Jude Cloud is a new data ecosystem developed to advance cures by reducing the technological barriers to data sharing and analysis. Developed by St. Jude Children’s Research Hospital in partnership with Microsoft and DNAnexus, St. Jude Cloud is the world’s largest public repository of pediatric cancer genomics data and offers unique analysis tools and visualizations in a secure cloud-based environment. To date, Microsoft Genomics Service has run more than 10,000 whole genome sequencing samples in support of the initiative.
Access to data is simple, fast and does not require downloading prior to exploration. Researchers can also upload their own data in a private, password-protected environment to use the St. Jude Cloud visualization and analysis tools. This webinar, which is sponsored by DNAnexus and Microsoft, will explore data, tools and visualizations that are available in St. Jude Cloud. Participants will also better understand how to use St. Jude Cloud to request, access and visualize St. Jude genomics data.
Speakers will provide an overview of this growing data-sharing platform that includes more than 5,000 whole-genome, 5,000 whole-exome and 1,200 RNA-Seq datasets from more than 5,000 pediatric cancer patients and survivors. They will also demonstrate the collection of bioinformatics tools and unique visualizations to help both experts and non-specialists gain novel insights from genomics data. Specific use cases will be covered.
Specific use cases will be covered. For example, the team discovered mutations connected to UV damage in a B-cell leukemia in work that was recently published in Nature. The finding led the team to use the rapid computing capabilities of the St. Jude Cloud to discover if other leukemia samples not included in the original study might have similar patterns of mutations.
The speakers for this event will be Dr. Scott Newman, the group lead of Bioinformatics Analysis at St. Jude Children's Research Hospital; and Clay McLeod, the manager of Bio Info Software Development at St. Jude Children's Research Hospital.
As leader of the clinical bioinformatics analysis team, Newman's group analyzes the whole genome and transcriptions sequence data generated for every St. Jude patient's tumor. In addition to that work, Dr. Newman's team is also leading the biological efforts of the St. Jude Cloud team.
McLeod joined St. Jude in 2016 as a senior software engineer, and is now manager of the development team for St. Jude Cloud, which involves putting genomic data, analysis tools and visualization into the cloud. He co-authored the Rapid RNA-Seq pipeline for St. Jude Cloud.
LabRoots will host the webinar October 23, 2018, beginning at 10 a.m. PDT, 1 p.m. EDT, to learn more about this event, discover the continuing education credit offered for the event, or to register for free, click here.
About St. Jude
St. Jude Children’s Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude is ranked the No. 1 pediatric cancer hospital by U.S. News & World Report. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.
DNAnexus, the global leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in North America, Europe, Asia-Pacific (including China), South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bio-agricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs globally. For more information on DNAnexus, please visit http://www.dnanexus.com or follow the company @DNAnexus.
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.